financetom
Business
financetom
/
Business
/
--Blackstone Plans to Take Out $800 Million Loan to Finance New York Office Purchase, Reuters Reports
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
--Blackstone Plans to Take Out $800 Million Loan to Finance New York Office Purchase, Reuters Reports
Feb 13, 2025 11:20 AM

01:50 PM EST, 02/13/2025 (MT Newswires) --

Price: 159.62, Change: -1.27, Percent Change: -0.79

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Chart Industries, Flowserve Terminate Merger Agreement
Chart Industries, Flowserve Terminate Merger Agreement
Jul 29, 2025
08:39 AM EDT, 07/29/2025 (MT Newswires) -- Chart Industries ( GTLS ) and Flowserve ( FLS ) terminated their previously announced merger agreement, the companies said in separate statements on Tuesday. Flowserve ( FLS ) said the termination follows the decision of its board not to submit a revised offer after being notified that Chart's board had determined that Baker...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Biotech firm ImmunoPrecise's FY25 revenue misses estimates
Biotech firm ImmunoPrecise's FY25 revenue misses estimates
Jul 29, 2025
Overview * ImmunoPrecise FY25 revenue was C$24.5 mln, missing analyst expectations * Record Q4 revenue of C$7.0 mln, driven by BioStrand segment growth * Q4 Adjusted EBITDA loss improved to C$0.3 mln, reflecting operational efficiency Outlook * Company anticipates completing divestiture of Dutch subsidiary soon * ImmunoPrecise to focus on AI-based product development * Company expects strategic steps to enhance...
Bausch Health to Acquire Durect for $63 Million
Bausch Health to Acquire Durect for $63 Million
Jul 29, 2025
08:39 AM EDT, 07/29/2025 (MT Newswires) -- Bausch Health ( BHC ) said Tuesday it has agreed to indirectly acquire Durect ( DRRX ) for $63 million in an all-cash transaction. Under the deal, Bausch Health ( BHC ) will pay $1.75 per share upfront for all of Durect's ( DRRX ) outstanding shares, with the potential for two additional...
Copyright 2023-2026 - www.financetom.com All Rights Reserved